Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis

  1. Carey, L.A.
  2. Loirat, D.
  3. Punie, K.
  4. Bardia, A.
  5. Diéras, V.
  6. Dalenc, F.
  7. Diamond, J.R.
  8. Fontaine, C.
  9. Wang, G.
  10. Rugo, H.S.
  11. Hurvitz, S.A.
  12. Kalinsky, K.
  13. O’Shaughnessy, J.
  14. Loibl, S.
  15. Gianni, L.
  16. Piccart, M.
  17. Zhu, Y.
  18. Delaney, R.
  19. Phan, S.
  20. Cortés, J.
Revista:
npj Breast Cancer

ISSN: 2374-4677

Any de publicació: 2022

Volum: 8

Número: 1

Tipus: Article

DOI: 10.1038/S41523-022-00439-5 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus